| scholarly article | Q13442814 |
| P2093 | author name string | Alberto Rubio-Tapia | |
| Joseph A Murray | |||
| P2860 | cites work | Celiac disease autoantibodies in severe autoimmune liver disease and the effect of liver transplantation | Q24642835 |
| HLA DQ gene dosage and risk and severity of celiac disease | Q24685893 | ||
| The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis | Q28211823 | ||
| Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma | Q28301149 | ||
| Risk of primary biliary liver cirrhosis in patients with coeliac disease: Danish and Swedish cohort data | Q30573244 | ||
| Celiac disease in autoimmune cholestatic liver disorders | Q34154921 | ||
| Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis | Q34477251 | ||
| American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. | Q34579599 | ||
| In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. | Q34649501 | ||
| The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences | Q35348722 | ||
| Increased risk of non-alcoholic fatty liver disease after diagnosis of celiac disease | Q35629725 | ||
| Autoimmune cholestatic liver disease in people with coeliac disease: a population-based study of their association. | Q36041175 | ||
| The world map of celiac disease. | Q36162310 | ||
| Causes of death in patients with celiac disease in a population-based Swedish cohort | Q38483066 | ||
| Intestinal involvement is not sufficient to explain hypertransaminasemia in celiac disease? | Q39347542 | ||
| Hepatic injury in adult coeliac disease | Q39446125 | ||
| Hypertransaminasemia in Newly Diagnosed Pediatric Patients With Celiac Disease | Q39466960 | ||
| The liver in coeliac disease | Q40165848 | ||
| ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries | Q40416496 | ||
| Prevalence of abnormal liver function tests in celiac disease and the effect of a gluten-free diet in the US population | Q40762887 | ||
| Prevalence of IgA antibodies to endomysium and tissue transglutaminase in primary biliary cirrhosis | Q43484025 | ||
| Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure | Q43557858 | ||
| High prevalence of celiac disease in autoimmune hepatitis detected by anti-tissue tranglutaminase autoantibodies. | Q44362815 | ||
| Hepatitis B vaccine nonresponse and celiac disease | Q45208004 | ||
| Searching for coeliac disease in patients with non-alcoholic fatty liver disease | Q47361870 | ||
| Clinicopathological and immunological characteristics and outcome of concomitant coeliac disease and non-alcoholic fatty liver disease in adults: a large prospective longitudinal study | Q50350904 | ||
| Interferon and ribavirin treatment for chronic hepatitis C may activate celiac disease. | Q50586107 | ||
| Accuracy of ultrasonography in predicting celiac disease. | Q51532122 | ||
| Prevalence and clinical significance of IgA anti-tissue transglutaminase antibodies in patients with chronic liver disease. | Q51679906 | ||
| Prevalence and associated factors of abnormal liver values in children with celiac disease. | Q51684944 | ||
| Mortality in coeliac disease: a population-based cohort study from a single centre in Southern Derbyshire, UK. | Q53281337 | ||
| Failure to respond to hepatitis B vaccine in children with celiac disease. | Q53573790 | ||
| Obstructive jaundice caused by enteropathy-associated T-cell lymphoma in a patient with celiac sprue. | Q53602101 | ||
| High prevalence of celiac sprue among patients with primary biliary cirrhosis. | Q53845320 | ||
| Celiac Disease | Q54165657 | ||
| Increased risk of nonalcoholic fatty liver disease in patients with coeliac disease on a gluten-free diet: beyond traditional metabolic factors | Q56369454 | ||
| Coeliac disease hidden by cryptogenic hypertransaminasaemia | Q57014316 | ||
| Celiac Disease and Risk of Liver Disease: A General Population-Based Study | Q57697794 | ||
| Prevalence of coeliac disease in primary biliary cirrhosis and of antimitochondrial antibodies in adult coeliac disease patients in Italy | Q63203956 | ||
| Primary sclerosing cholangitis and celiac disease. A novel association | Q67966813 | ||
| Hepatic lesions in adult coeliac disease | Q68909370 | ||
| [Hepatic damage in celiac disease in children] | Q69732617 | ||
| Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings | Q70008904 | ||
| Prevalence of hypertransaminasemia in adult celiac patients and effect of gluten-free diet | Q72016125 | ||
| Liver abnormalities associated with celiac sprue. How common are they, what is their significance, and what do we do about them? | Q72037157 | ||
| Celiac sprue: another autoimmune syndrome associated with hepatitis C | Q73485556 | ||
| Screening patients with celiac disease for primary biliary cirrhosis and vice versa | Q73747762 | ||
| Gluten sensitivity in patients with primary biliary cirrhosis | Q74526459 | ||
| Chronic unexplained hypertransaminasemia may be caused by occult celiac disease | Q74529905 | ||
| Adult celiac disease: US signs | Q77400824 | ||
| Prevalence and clinical importance of hypertransaminasaemia in coeliac disease | Q77763274 | ||
| Celiac disease during interferon treatment | Q78037659 | ||
| Celiac disease is not associated with chronic hepatitis C | Q79988541 | ||
| Celiac disease-related autoantibodies in end-stage autoimmune liver diseases: what is the message? | Q80867366 | ||
| Gluten intake interferes with the humoral immune response to recombinant hepatitis B vaccine in patients with celiac disease | Q81385166 | ||
| The liver in celiac disease | Q81517623 | ||
| Coeliac disease and the liver: spectrum of liver histology, serology and treatment response at a tertiary referral centre | Q89125888 | ||
| Celiac Disease and Liver Disorders: From Putative Pathogenesis to Clinical Implications | Q90009862 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 167-176 | |
| P577 | publication date | 2019-03-01 | |
| P1433 | published in | Clinics in liver disease | Q26842322 |
| P1476 | title | The Liver and Celiac Disease | |
| P478 | volume | 23 |
Search more.